Clin2
NCT07279194Likely a fitRecruiting

Study of HDM1005 for weight loss in Chinese adults without diabetes

Obesity & Overweight

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
825 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • Your BMI is 28 or higher, or 24 or higher with a weight-related health condition (like high blood pressure or fatty liver)
  • You have not had diabetes (type 1 or type 2)
  • Your weight has stayed steady (not changed by more than 5%) in the last 3 months
  • You have not taken certain weight-loss or diabetes medications in the last 3 months
  • You are willing to use contraception if needed and follow the study plan

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06520540Not yet recruiting· Phase 1
HDM1002 tablets for weight loss in Chinese adults

This trial tests an experimental tablet called HDM1002 for weight loss in Chinese adults who are overweight or obese. It aims to see if the medication is safe and helps with weight management.

Shanghai, Shanghai Municipality
NCT07521631Recruiting· Phase 2
HDM1005 versus Tirzepatide for weight management in obese adults

This study tests whether a new injectable medication called HDM1005 works as well as tirzepatide (a GLP-1 drug) for weight loss in adults with obesity but no diabetes. Both medications work similarly in the body to help control appetite and weight.

Shanghai
NCT06885021Not yet recruiting· Phase 3
Study of HDM1002 for weight loss in overweight and obese adults

This trial tests a new medication, HDM1002, to help people with excess weight lose weight and keep it off. You may qualify if you have a high BMI or a lower BMI with weight-related health problems, and you have struggled to lose weight through diet and exercise alone.

NCT06886126Recruiting· Phase 2
Testing HDM1005 injection for weight loss in adults with obesity

This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.

Nanjing
NCT07110766Not yet recruiting· Phase 1
Study of MDR-001 for obesity or overweight people

This trial tests an experimental drug, MDR-001, to see if it is safe and helps with weight loss. It is for Chinese adults who are obese or overweight and have related health problems like pre-diabetes or high blood pressure.

Ch’ang-ch’un, Jilin
NCT07394114Recruiting· Phase 3
Study of a new medicine for type 2 diabetes not controlled by diet and exercise

This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.

Beijing

Hear when a new Obesity & Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.